NDRA EBITDA | ENDRA LIFE SCIENCES INC.

ENDRA LIFE SCIENCES INC. (NDRA) EBITDA

2026-06-30: Basis Reported; EBITDA -$1.48M*; Operating income -$1.48M; Depreciation and amortization $8.16K*.
2026-03-31: Basis Reported; EBITDA -$2.16M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$1.61M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$1.36M*; Operating income -$1.37M; Depreciation and amortization $10.79K*.

Complete source-backed ebitda history.

Available history: 2016-03-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$1.48M*	-$1.48M	$8.16K*	(m)	(m)	(m)	-$927.56K*	(m)	$233.66K	(m)	(m)
2026-03-31	Reported	-$2.16M	(m)	(m)	(m)	(m)	(m)	-$1.12M	(m)	$776.41K	(m)	(m)
2025-12-31	Reported	-$1.61M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$1.36M*	-$1.37M	$10.79K*	(m)	(m)	$0.00*	-$1.16M*	(m)	$432.11K	(m)	(m)
2025-06-30	Reported	-$1.29M*	-$1.30M	$9.36K*	(m)	(m)	$0.00*	-$1.11M*	(m)	$381.06K	(m)	$0.00
2025-03-31	Reported	-$1.46M	(m)	(m)	(m)	(m)	$17.28K	-$1.29M	(m)	$528.68K	(m)	$0.00
2024-12-31	Reported	-$4.29M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	(m)	-$1.51M	(m)	(m)	(m)	$0.00*	-$1.66M*	(m)	$794.44K	(m)	$0.00
2024-06-30	Reported	(m)	-$2.23M	(m)	(m)	(m)	-$11.00K*	-$2.08M*	(m)	$716.37K	(m)	$0.00
2024-03-31	Reported	(m)	-$2.78M	(m)	(m)	(m)	$27.00K	-$2.14M	(m)	$1.04M	(m)	$0.00
2023-09-30	Reported	(m)	-$3.13M	(m)	(m)	(m)	$0.00*	-$2.60M*	(m)	$1.63M	(m)	$0.00
2023-06-30	Reported	-$2.96M*	-$2.99M	$35.27K*	(m)	(m)	$0.00*	-$2.27M*	(m)	$1.40M	(m)	$0.00
2023-03-31	Reported	-$2.9M	(m)	(m)	(m)	(m)	$27.00K	-$2.51M	(m)	$1.39M	(m)	$0.00
2022-12-31	Reported	-$3.28M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$3.39M*	-$3.42M	$23.79K*	(m)	(m)	$14.86K*	-$3.25M*	(m)	$1.83M	(m)	$0.00
2022-06-30	Reported	-$3.55M*	-$3.57M	$21.70K*	(m)	(m)	$59.80K*	-$3.33M*	(m)	$1.85M	(m)	$0.00
2022-03-31	Reported	-$2.84M	(m)	(m)	(m)	(m)	$89.35K	-$3.10M	(m)	$1.21M	(m)	$0.00
2021-12-31	Reported	-$3.05M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$2.62M*	-$2.65M	$29.82K*	(m)	(m)	$0.00*	-$2.75M*	(m)	$1.17M	(m)	$0.00
2021-06-30	Reported	-$3.17M*	-$3.20M	$33.73K*	(m)	(m)	$0.00*	-$2.80M*	(m)	$1.74M	(m)	$0.00
2021-03-31	Reported	-$2.54M	(m)	(m)	(m)	(m)	$45.00K	-$2.92M	(m)	$1.14M	(m)	$0.00
2020-12-31	Reported	-$2.2M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$3.25M*	-$3.26M	$1.10K*	(m)	(m)	-$11.87K*	-$2.13M*	(m)	$1.77M	(m)	$0.00
2020-06-30	Reported	-$2.87M*	-$2.89M	$22.43K*	(m)	(m)	$0.00*	-$3.45M*	(m)	$1.49M	(m)	$0.00
2020-03-31	Reported	-$3.08M	(m)	(m)	(m)	(m)	$22.35K	-$3.09M	(m)	$1.52M	(m)	$0.00
2019-12-31	Reported	-$3.11M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$2.62M*	-$2.64M	$19.93K*	(m)	(m)	$0.00*	-$2.48M*	$0.00	$1.47M	(m)	$0.00
2019-06-30	Reported	-$2.31M*	-$2.33M	$20.11K*	(m)	(m)	-$1.00*	-$1.66M*	$0.00	$1.30M	(m)	$0.00
2019-03-31	Reported	-$2.73M	(m)	(m)	(m)	(m)	$5.24K	-$2.54M	$0.00	$1.77M	(m)	$0.00
2018-12-31	Reported	-$1.98M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$2.34M*	-$2.36M	$18.04K*	(m)	(m)	$100.00K*	-$1.47M*	$0.00	$1.16M	(m)	$0.00
2018-06-30	Reported	-$1.81M*	-$1.82M	$14.87K*	(m)	(m)	$0.00*	-$1.88M*	$0.00	$839.76K	(m)	$0.00
2018-03-31	Reported	-$2.82M	(m)	(m)	(m)	-45712.33%	$0.00	-$2.45M	$0.00	$1.67M	(m)	$0.00
2017-12-31	Reported	-$2.28M	(m)	(m)	(m)	-33302.35%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$895.78K*	-$910.93K	$15.16K*	(m)	(m)	$0.00*	-$546.61K*	$118.27K	$300.53K	(m)	$0.00
2017-06-30	Reported	-$1.04M*	-$1.06M	$15.27K*	(m)	(m)	(m)	-$1.14M*	$51.43K	$174.72K	(m)	$0.00
2017-03-31	Reported	-$345,007.00	(m)	(m)	(m)	(m)	(m)	-$236.27K	(m)	$95.81K	(m)	$0.00
2016-12-31	Reported	-$302,557.00	(m)	(m)	(m)	-58.68%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$588.77K*	-$605.11K	$16.34K*	(m)	(m)	(m)	$0.00*	(m)	$137.54K	(m)	$0.00
2016-06-30	Reported	-$478.22K*	-$494.31K	$16.09K*	(m)	(m)	(m)	-$715.70K*	(m)	$103.64K	(m)	(m)
2016-03-31	Reported	-$357,275.00	(m)	(m)	(m)	(m)	(m)	-$53.76K	(m)	$198.88K	(m)	$0.00

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$5.72M	(m)	(m)	(m)	(m)	$17.28K	-$5.18M	(m)	$1.85M	(m)	(m)
2024-12-31	Reported	-$10.77M	(m)	(m)	(m)	(m)	$16.00K	-$7.40M	(m)	$3.19M	(m)	$0.00
2023-12-31	Reported	(m)	-$10.52M	(m)	(m)	(m)	$33.88K	-$9.55M	(m)	$5.00M	(m)	$0.00
2022-12-31	Reported	-$13.06M	(m)	(m)	(m)	(m)	$202.58K	-$12.77M	(m)	$6.55M	(m)	$0.00
2021-12-31	Reported	-$11.38M	(m)	(m)	(m)	(m)	$45.00K	-$11.12M	(m)	$5.48M	(m)	$0.00
2020-12-31	Reported	-$11.4M	(m)	(m)	(m)	(m)	$75.33K	-$10.75M	(m)	$5.92M	(m)	$0.00
2019-12-31	Reported	-$10.76M	(m)	(m)	(m)	(m)	$43.59K	-$8.59M	(m)	$6.57M	(m)	$0.00
2018-12-31	Reported	-$8.95M	(m)	(m)	(m)	-144973.96%	$100.00K	-$7.70M	(m)	$4.72M	(m)	$0.00
2017-12-31	Reported	-$4.56M	(m)	(m)	(m)	-1298.15%	$7.86K	-$3.30M	(m)	$1.93M	(m)	$0.00
2016-12-31	Reported	-$1.73M	(m)	(m)	(m)	-334.93%	(m)	-$1.32M	(m)	$495.38K	(m)	$0.00

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
IRIDEX CORP (IRIX)	United States	$0.011B
Nuwellis, Inc. (NUWE)	United States	$0.003B
QT IMAGING HOLDINGS, INC. (QTI)	United States	$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)	United States	$0.052B
Outset Medical, Inc. (OM)	United States	$0.059B	-1.09
Streamex Corp. (STEX)	United States	$0.089B	-0.19
Nexalin Technology, Inc. (NXL)	United States	$0.094B
Neuraxis, INC (NRXS)	United States	$0.097B
electroCore, Inc. (ECOR)	United States	$0.102B
Vivani Medical, Inc. (VANI)	United States	$0.111B